Jesper Lindhardsen

8.9k total citations · 3 hit papers
65 papers, 6.7k citations indexed

About

Jesper Lindhardsen is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Jesper Lindhardsen has authored 65 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 22 papers in Cardiology and Cardiovascular Medicine and 15 papers in Immunology. Recurrent topics in Jesper Lindhardsen's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Jesper Lindhardsen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Rheumatoid Arthritis Research and Therapies (12 papers). Jesper Lindhardsen collaborates with scholars based in Denmark, United States and United Kingdom. Jesper Lindhardsen's co-authors include Gunnar Gislason, Christian Torp‐Pedersen, Peter Riis Hansen, Jonas Bjerring Olesen, Ole Ahlehoff, Gregory Y.H. Lip, Lars Køber, Christian Selmer, Janne Schurmann Tolstrup and A. M. Schjerning Olsen and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Jesper Lindhardsen

62 papers receiving 6.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

2011 1.1k citations Jonas Bjerring Olesen, Mona Hansen et al. BMJ profile →
Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

2013 869 citations Mads Wissenberg, Freddy Lippert et al. JAMA profile →
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

2012 674 citations Jonas Bjerring Olesen, Lars Køber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesper Lindhardsen Denmark	32	3.1k	1.2k	1.0k	1.0k	923	65	6.7k
Jonas Bjerring Olesen Denmark	46	6.6k 2.1×	607 0.5×	1.4k 1.3×	572 0.6×	2.2k 2.4×	158	9.8k
Anne‐Mette Hvas Denmark	44	2.0k 0.6×	219 0.2×	724 0.7×	1.2k 1.1×	1.2k 1.3×	306	6.3k
Tami L. Bair United States	47	3.7k 1.2×	460 0.4×	1.5k 1.4×	393 0.4×	352 0.4×	195	7.6k
Steen Z. Abildstrøm Denmark	36	4.1k 1.3×	476 0.4×	428 0.4×	276 0.3×	455 0.5×	110	6.7k
Dongjie Fan United States	18	3.4k 1.1×	233 0.2×	1.1k 1.1×	305 0.3×	328 0.4×	38	11.1k
Barbara A. Hutten Netherlands	51	3.9k 1.3×	786 0.7×	657 0.6×	280 0.3×	1.9k 2.1×	215	10.3k
Thomas Mueller Austria	37	2.5k 0.8×	1.3k 1.1×	544 0.5×	441 0.4×	155 0.2×	105	4.9k
Susan J. Zieman United States	35	6.5k 2.1×	254 0.2×	800 0.8×	166 0.2×	492 0.5×	62	9.1k
Søren Lund Kristensen Denmark	36	2.9k 0.9×	557 0.5×	657 0.6×	321 0.3×	208 0.2×	134	6.4k
Giacomo Zoppini Italy	60	2.6k 0.8×	506 0.4×	7.1k 6.8×	405 0.4×	226 0.2×	166	12.5k

Countries citing papers authored by Jesper Lindhardsen

Since Specialization

Citations

This map shows the geographic impact of Jesper Lindhardsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Lindhardsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Lindhardsen more than expected).

Fields of papers citing papers by Jesper Lindhardsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Lindhardsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Lindhardsen. The network helps show where Jesper Lindhardsen may publish in the future.

Co-authorship network of co-authors of Jesper Lindhardsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Lindhardsen. A scholar is included among the top collaborators of Jesper Lindhardsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Lindhardsen. Jesper Lindhardsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leffers, Henrik, Bo Baslund, Jesper Lindhardsen, Sophine Boysen Krintel, & Niels Graudal. (2024). Abatacept and tofacitinib in refractory sarcoidosis: drug survival, safety, and treatment response. Clinical and Experimental Rheumatology. 42(11). 2167–2174. 1 indexed citations

Delcoigne, Bénédicte, Tine Iskov Kopp, Elizabeth V. Arkema, et al.. (2023). Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD Open. 9(1). e002924–e002924. 2 indexed citations

Gyldenløve, Mette, Howraman Meteran, Jennifer Astrup Sørensen, et al.. (2023). Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO). The Lancet Regional Health - Europe. 30. 100639–100639. 25 indexed citations

Cordtz, René, Jesper Lindhardsen, Salome Kristensen, et al.. (2023). Temporal trends in mortality in patients with rheumatoid arthritis: a Danish population-based matched cohort study. Lara D. Veeken. 63(4). 1049–1057. 7 indexed citations

Sun, Guoli, Emil Loldrup Fosbøl, Adelina Yafasova, et al.. (2022). Long‐term risk of heart failure and other adverse cardiovascular outcomes in primary Sjögren's syndrome. Journal of Internal Medicine. 293(4). 457–469. 9 indexed citations

Rasmussen, Rasmus V., et al.. (2021). Rheumatoid arthritis mimicking infective endocarditis with severe aortic regurgitation and aortic root abscess: a case report. European Heart Journal - Case Reports. 5(1).

Olsen, Anne‐Marie Schjerning, Jesper Lindhardsen, Gunnar Gislason, et al.. (2015). Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study. BMJ. 351. h5096–h5096. 29 indexed citations

Faurschou, Mikkel, Magnus Glindvad Ahlström, Jesper Lindhardsen, Bo Baslund, & Niels Obel. (2015). Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study. Lara D. Veeken. 55(4). 649–653. 13 indexed citations

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jannik Langtved Pallisgaard, et al.. (2015). NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study. European Heart Journal - Cardiovascular Pharmacotherapy. 1(2). 107–114. 14 indexed citations

10.

Ahlehoff, Ole, Lone Skov, Gunnar Gislason, et al.. (2014). Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort. Journal of the European Academy of Dermatology and Venereology. 29(6). 1128–1134. 148 indexed citations

11.

Kristensen, Søren Lund, Jesper Lindhardsen, Ole Ahlehoff, et al.. (2013). Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. EP Europace. 16(4). 477–484. 114 indexed citations

12.

Wissenberg, Mads, Freddy Lippert, Fredrik Folke, et al.. (2013). Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest. JAMA. 310(13). 1377–1377. 869 indexed citations breakdown →

13.

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2012). Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction. Circulation. 126(16). 1955–1963. 82 indexed citations

14.

Lindhardsen, Jesper, Ole Ahlehoff, Gunnar Gislason, et al.. (2012). FRI0115 Non-steroidal anti-inflammatory drug use and the risk of cardiovascular disease in patients with rheumatoid arthritis – is there a risk?. Annals of the Rheumatic Diseases. 71. 349–349. 10 indexed citations

15.

Selmer, Christian, Jonas Bjerring Olesen, Jesper Lindhardsen, et al.. (2012). SUBCLINICAL THYROID DISEASE AND RISK OF NEW-ONSET ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 59(13). E662–E662. 1 indexed citations

16.

Charlot, Mette, Lars Nielsen, Jesper Lindhardsen, et al.. (2012). Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. European Heart Journal. 33(20). 2527–2534. 13 indexed citations

17.

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2011). Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction. Circulation. 123(20). 2226–2235. 243 indexed citations

18.

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2011). NSAID TREATMENT IS ASSOCIATED WITH PERSISTENTLY INCREASED RISK OF DEATH IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A NATIONWIDE STUDY. Journal of the American College of Cardiology. 57(14). E1027–E1027.

19.

Charlot, Mette, Erik Lerkevang Grove, Peter Riis Hansen, et al.. (2011). Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 342(may11 1). d2690–d2690. 150 indexed citations

20.

Ahlehoff, Ole, Gunnar Gislason, Mette Charlot, et al.. (2010). Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Journal of Internal Medicine. 270(2). 147–157. 359 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact